8-K: Chain Bridge I Announces CFO Resignation and Appointment

Chain Bridge I has announced the resignation of its CFO, Roger Lazarus, and the appointment of Andrew Kucharchuk as his successor, effective April 1, 2024.

Summary

• Chain Bridge I's Chief Financial Officer, Roger Lazarus, resigned effective April 1, 2024.
• Andrew Kucharchuk was appointed as the new Chief Financial Officer, also effective April 1, 2024.
• Mr. Lazarus will serve as an advisor to the company through the end of April 2024 to ensure a smooth transition.
• Mr. Kucharchuk's compensation will be $7,500 upon execution of his consulting agreement and $7,500 per month until August 31, 2024.
• Mr. Kucharchuk may also be eligible for performance bonuses at the discretion of Fulton AC I LLC.
• Mr. Kucharchuk has a history of serving in executive roles at Theralink Technologies, Inc. and OncBioMune, Inc.
• Mr. Kucharchuk has also served as Chairman and Chief Operating Officer of Adhera Therapeutics, Inc.
• Mr. Kucharchuk is now bound by the terms of the Letter Agreement dated November 9, 2021, and has entered into an Indemnification Agreement with the company.

Sentiment

Score: 6

Explanation: The document reflects a neutral event, a change in CFO, which is a normal part of business operations. The new CFO has relevant experience, but the consulting agreement structure introduces a slight element of uncertainty.

Positives

• The company has quickly appointed a successor to the departing CFO, ensuring a smooth transition.
• The new CFO, Andrew Kucharchuk, has a strong background in finance and executive leadership within the biotechnology sector.
• Mr. Lazarus will remain as an advisor through April 2024 to assist with the transition.

Negatives

• The resignation of the CFO, Roger Lazarus, could create some uncertainty for investors.
• The new CFO's compensation is structured as a consulting agreement, which may raise questions about his long-term commitment to the company.

Risks

• The transition of CFOs could potentially disrupt the company's financial operations.
• The reliance on a consulting agreement for the new CFO's compensation may not align his interests with the long-term goals of the company.
• The potential for performance bonuses at the discretion of Fulton AC I LLC could create a conflict of interest.

Future Outlook

The company has not provided any specific forward-looking statements in this document, but the appointment of a new CFO is expected to ensure continued financial leadership.

Management Comments

• Roger Lazarus notified the board of directors of his resignation, effective immediately.
• Andrew Kucharchuk succeeded Mr. Lazarus as the Company's Chief Financial Officer, effective April 1, 2024.

Industry Context

Executive changes are common in the corporate world, and this announcement reflects a transition in financial leadership at Chain Bridge I. The appointment of a new CFO with experience in the biotechnology sector suggests a potential focus on growth and strategic financial management.

Comparison to Industry Standards

• The compensation structure for the new CFO, a consulting agreement with a monthly fee and potential bonuses, is not uncommon for interim or transitional roles in smaller companies.
• The appointment of a CFO with prior experience in similar roles at other companies like Theralink Technologies and OncBioMune is a common practice to ensure a smooth transition and bring relevant expertise.
• The use of an indemnification agreement is standard practice to protect officers and directors from potential liabilities.

Management Changes

Stakeholder Impact

• Shareholders may react to the change in CFO, but the appointment of an experienced successor should mitigate concerns.
• Employees may experience a transition in leadership within the finance department.
• Creditors and suppliers may not be significantly impacted by this change.

Next Steps

• Andrew Kucharchuk will assume his role as CFO and begin his consulting agreement.
• Roger Lazarus will serve as an advisor through the end of April 2024 to assist with the transition.

Key Dates

Keywords

CFO, Chief Financial Officer, executive change, resignation, appointment, consulting agreement, financial leadership, Chain Bridge I, Andrew Kucharchuk, Roger Lazarus